Regeneron Pharmaceuticals (REGN) Fair Value & DCF
REGN$959.41+43.35 +4.73%
Market cap$99.23BEnterprise value$94.85BRevenue (TTM)$16.90BMarket positionTop 25%
Score
58
Neutral
Value
53
Quality
69
Growth
52
Regeneron Pharmaceuticals, Inc. (REGN) trades at $959.41 on $99.23B of equity value, with a trailing P/E of 19.67. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.